ATARA Biotherapeutics (ATRA) Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive MS in Late-Breaking e-Poster at EAN
Go back to ATARA Biotherapeutics (ATRA) Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive MS in Late-Breaking e-Poster at EAN| (NASDAQ: ATRA) | Delayed: 10.36 +0.13 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.23 | 52 Week High | $40.80 | |||
| Open | $10.27 | 52 Week Low | $12.45 | |||
| Day High | $10.38 | P/E | N/A | |||
| Day Low | $10.03 | EPS | $0.00 | |||
| Volume | 45,269 | |||||
